High anillin expression was associated with more aggressive estrogen and progesterone receptor-deficient (ER-, PR-) breast tumors but appeared to be independent of the human epidermal growth factor receptor 2 (HER2) status [28, 31, 35]. This evidence concerns the gene ERBB2 and breast neoplasm.